Following our previous post regarding the public consultation recently carried out by the UK Intellectual Property Office (UK IPO or IPO)

An Advocate General of the Court of Justice of the EU has handed down his non-binding opinion on the interpretation of EU law about supplementary protection certificates for combination medicinal products.

This article explores how a well‑structured intellectual property strategy underpins every ambitious fashion business, protecting everything from brand identity to innovative materials and manufacturing techniques.

Counterfeit products are everywhere. According to the US National Crime Prevention Council, it is now an industry that boasts an annual turnover of $2 trillion...

Standards ensure the interoperability of products relating to the same technology from different manufacturers.

It includes the activities of your competitors in terms of their pending and granted rights and can also reveal information about the direction of their R&D focus.

Biotechnology and chemistry startups face a critical question when filing priority patent applications: how much experimental data is actually required? While the answer depends on the predictability of the technology, the European Patent Office's strict disclosure standards mean that insufficient technical support can invalidate priority claims entirely, leaving innovations vulnerable to competitor filings and prior art that emerges during the assumed protection period.

According to data released in March by the World Intellectual Property Office, WIPO, Huawei, Samsung and Qualcomm retained their positions as the top three filers of international patent applications filed in 2023.

In April 2023, the European Commission adopted a comprehensive package of proposed reforms to the legislation governing the authorisation of medicines in the EU.